MSTN and diabetes mellitus: In multivariate analysis, myostatin > 2170 pg/mL remained significantly associated with an increased risk of AV access events (Adjusted HR = 1.90, 95% CI [1.02–3.55]; p = 0.044) when adjusted for BMI, SBP before dialysis > 140 mmHg, and history of diabetes (Table 5).